Through an emergency authorization, the FDA approved hydroxychloroquine for what is called ‘off label’ use, meaning doctors can prescribe it in limited fashion for COVID-19 patients, but FDA has yet to determine if it is effective.
Scientists in the United States have begun testing an anti-malarial drug as a potential treatment for coronavirus patients.
President Donald Trump has touted the benefits of hydroxychloroquine despite warnings from health experts of its long list of side effects.
Its efficacy in curing COVID-19 remains unproven and a specific vaccine for the virus may still be months away.
Al Jazeera’s Gabriel Elizondo reports from New Jersey, US.